RHabdomyosarcoma: Response with chemotherapy prior to radiation in patients with gross residual disease
- 1 February 1977
- Vol. 39 (2) , 665-670
- https://doi.org/10.1002/1097-0142(197702)39:2<665::aid-cncr2820390244>3.0.co;2-b
Abstract
One hundred and ten Group III patients enrolled in the IRS Study have been reviewed. Of these, 39 are fully and 56 are partially evaluable. Combining the data for both groups, 77/95 (81%) have shown complete or partial response/no measurable disease and this has been maintained in 53/95 (56%). No patient received premature RT for local progression during the time of pre-radiation chemotherapy. However, 15/95 patients have shown local recurrence or direct extension to neighboring tissues; 13/15 could be reviewed. Only 3/13 have recurred at a time related to the delay in starting radiation. Overall survival for Group III patients is 72%-85% (Regimen F and Regimen E respectively).This publication has 17 references indexed in Scilit:
- Acute and late effects on normal tissues following combined chemo- and radiotherapy for childhood rhabdomyosarcoma and Ewing's sarcomaCancer, 1976
- Local control of embryonal rhabdomyosarcoma in children by radiation therapy when combined with concomitant chemotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1976
- The intergroup rhabdomyosarcoma study (NIH): Objectives and clinical staging classificationJournal of Pediatric Surgery, 1975
- CHILDHOOD RHABDOMYOSARCOMAAmerican Journal of Roentgenology, 1975
- Reasonable Surgery for R habdomyosarcomaAnnals of Surgery, 1973
- Rhabdomyosarcoma in childrenThe American Journal of Surgery, 1973
- Embryonal Rhabdomyosarcoma of the Middle Ear with Long-Term SurvivalNew England Journal of Medicine, 1971
- Radiation Therapy for RhabdomyosarcomaRadiology, 1968
- RADIATION THERAPY IN THE MANAGEMENT OF CHILDREN WITH GYNECOLOGIC CANCERSAnnals of the New York Academy of Sciences, 1967
- EMBRYONAL RHABDOMYOSARCOMAAmerican Journal of Roentgenology, 1967